Follow-up Evaluating Clinical and Radiological Outcomes of Total Shoulder Arthroplasty With Permedica's MIRAI Prosthesis

NCT ID: NCT05128500

Last Updated: 2025-09-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

76 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-07-12

Study Completion Date

2025-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational study is conducted in order to evaluate the effectiveness of the primary total shoulder arthroplasty with the Permedica's MIRAI Modular Shoulder Prosthesis System on the general population of patients who are about to undergo this surgery for every indication. Patients requiring a revision shoulder arthroplasty will not be enrolled.

The effectiveness will be evaluated in terms of recovery of shoulder function and stability of the prosthetic implant. The incidence of complications, adverse and serious adverse events will also be studied. Additional study aim is to evaluate a medium/long term survival of the prosthesis.

The duration of the study per single subject is 5 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cuff Tear Arthropathy Primary Osteoarthritis Secondary Osteoarthritis Shoulder Osteoarthritis Rheumatoid Arthritis Shoulder Psoriatic Arthritis Fracture, Shoulder Avascular Necrosis of Humerus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Total Shoulder Arthroplasty with Permedica's MIRAI

Total Shoulder Arthroplasty with Permedica's MIRAI Modular Shoulder Prosthesis System

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* both genders
* at least 18 years old of age
* undergoing a primary total shoulder arthroplasty with MIRAI® Prosthesis System (anatomic or reverse, stemless or stemmed).
* Signed informed consent

Exclusion Criteria

* Patients requiring a revision shoulder arthroplasty
* Persistent chronic or acute infections and all septic conditions
* Persistent osteomyelitis local or systemic
* Allergy or hypersensitivity to the substances contained in the materials of the implanted components
* Acute or chronic neurological and/or musculoskeletal impairment which compromises the shoulder joint function such as an axillary nerve injury affecting the deltoid muscle
* Inadequate bone structure which cannot guarantee stability to the prosthetic components
* Several vascular, nerve or muscular disorders, which compromise related extremities
* Marked osteoporosis, osteomalacia
* Hypotrophy of the periarticular soft tissues
* Dysmetabolic diseases such as, for example, kidney failure or systemic diseases
* Muscular insufficiency
* Active neoplastic or metastatic diseases
* Any other clinical or physical condition that can invalidate the surgery, the rehabilitation or the prosthesis stability
* Patient unwilling or unable to undergo the rehabilitation or to return to follow-up visits
* Women in pregnancy, childbearing potential or breastfeeding
* Involvement in other ongoing studies or clinical trial.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Permedica spa

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lorenzo Banci

Role: STUDY_DIRECTOR

Permedica

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

go:h - Gelenkchirurgie Orthopädie: Hannover

Hanover, , Germany

Site Status

Krankenhaus Reinbek St. Adolf-Stilt

Reinbek, , Germany

Site Status

ULSS 1 Dolomiti - Presidio Ospedaliero Santa Maria del Prato di Feltre

Feltre, , Italy

Site Status

Orthopädische Klinik Luzern - OKL

Lucerne, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany Italy Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MIRAI CLH-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

INHANCE Stemless Reverse Shoulder IDE
NCT06323980 RECRUITING NA
FH ORTHO Shoulder Observatory
NCT06511856 RECRUITING